Utsarga Adhikary - Publications
Affiliations: | Harvard University, Cambridge, MA, United States |
Area:
Cancer BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2024 | McHenry MW, Shi P, Camara CM, Cohen DT, Rettenmaier TJ, Adhikary U, Gygi MA, Yang K, Gygi SP, Wales TE, Engen JR, Wells JA, Walensky LD. Covalent inhibition of pro-apoptotic BAX. Nature Chemical Biology. PMID 38233584 DOI: 10.1038/s41589-023-01537-6 | 0.521 | |||
2023 | Adhikary U, Paulo JA, Godes M, Roychoudhury S, Prew MS, Ben-Nun Y, Yu EW, Budhraja A, Opferman JT, Chowdhury D, Gygi SP, Walensky LD. Targeting MCL-1 triggers DNA damage and an anti-proliferative response independent from apoptosis induction. Cell Reports. 42: 113176. PMID 37773750 DOI: 10.1016/j.celrep.2023.113176 | 0.543 | |||
2022 | Prew MS, Adhikary U, Choi DW, Portero EP, Paulo JA, Gowda P, Budhraja A, Opferman JT, Gygi SP, Danial NN, Walensky LD. MCL-1 is a master regulator of cancer dependency on fatty acid oxidation. Cell Reports. 41: 111445. PMID 36198266 DOI: 10.1016/j.celrep.2022.111445 | 0.53 | |||
2020 | Cathcart AM, Bird GH, Wales TE, Herce HD, Harvey EP, Hauseman ZJ, Newman CE, Adhikary U, Prew MS, Oo T, Lee S, Engen JR, Walensky LD. Targeting a helix-in-groove interaction between E1 and E2 blocks ubiquitin transfer. Nature Chemical Biology. PMID 32807965 DOI: 10.1038/S41589-020-0625-7 | 0.405 | |||
Show low-probability matches. |